.gif)
- Molecular cancer therapeutics
-
影響因子：
5.599
-
I S S N：
1535-7163
-
出 版 社：
American Association for Cancer Research, Inc.
-
出 版 地：
Philadelphia, PA
-
出版國家：
United States
-
刊 期：
月刊
-
創(chuàng)刊時間：
2001
-
語 種：
英文
-
審稿周期：
平均3.6月
-
中科院分區(qū)：
2
-
投稿命中率：
命中率約37.5%
-
國外數(shù)據(jù)庫收錄：
IM
-
中國收錄文章數(shù)：
53
-
5年影響因子：
5.72
-
研究領(lǐng)域：
抗癌藥物、抗腫瘤藥、基因治療、腫瘤、藥理學(xué)
-
官方鏈接：
http://mct.aacrjournals.org/
-
投稿須知：
http://mct.aacrjournals.org/
期刊介紹：
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.
